News & Articles
Selected Filters:
Purigen Biosystems gets CE mark for nucleic acid isolation system
Company rapidly expanding commercial operations to enable more researchers to extract higher yields of DNA and RNA from FFPE samples in one hour with minimal hands-on time
Advancing oncology therapeutics development with 2D & 3D cell screening
Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies
Safeguarding public health against antimicrobial-resistant bacteria
Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples
5 expert webinars you won't want to miss
Explore topics from LC-MS for oligos, peptides, glycans, and large molecule characterization to 3D cell culture for anticancer therapies
Accelerating microbiome research: The new reference material improving data quality
Dr. Raul Cano, Chief Scientific Officer at The BioCollective, discusses how to increase sequencing data accuracy and reproducibility and the future of the microbiome in healthcare
Using CRISPR as a research tool to develop cancer treatments
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology
An on-off switch for gene editing
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged
Abbott's Panbio Rapid Antigen Test gains CE Mark for use on children
First rapid antigen test with performance data on children
Doubling the resolution of structured illumination microscopy
New image reconstruction algorithm enhances super-resolution microscope ZEISS Elyra 7
Biotinylated heparan sulfate antibodies
Cancer immunotherapies: How single-cell sequencing can aid informed decision-making
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
SelectScience wins 2021 Queen’s Award for Enterprise
Team dedicates the award to the scientists, healthcare professionals and scientific manufacturers who have risen to the challenges of the pandemic
CardiNor has secured NOK12 million (US$1.46M) to commercialize first secretoneurin ELISA test
The growing heart failure pandemic increases need for new innovative assays
























